AAAAAA

   
Results: 1-21 |
Results: 21
ETHANOL INCREASES RISK OF ACETAMINOPHEN HEPATOTOXICITY IN HEALTHY-ADULTS
Authors: CHIEN JY THUMMEL KE SLATTERY JT RO H NELSON SD LOWN KS WATKINS PB
Citation: Jy. Chien et al., ETHANOL INCREASES RISK OF ACETAMINOPHEN HEPATOTOXICITY IN HEALTHY-ADULTS, Hepatology, 28(4), 1998, pp. 380-380
DRUG-INDUCED LIVER-DISEASE
Authors: LOWN KS
Citation: Ks. Lown, DRUG-INDUCED LIVER-DISEASE, Current opinion in gastroenterology, 14(3), 1998, pp. 208-214
SEQUENCES OF INTESTINAL AND HEPATIC CYTOCHROME-P450 3A4 CDNAS ARE IDENTICAL
Authors: LOWN KS GHOSH M WATKINS PB
Citation: Ks. Lown et al., SEQUENCES OF INTESTINAL AND HEPATIC CYTOCHROME-P450 3A4 CDNAS ARE IDENTICAL, Drug metabolism and disposition, 26(2), 1998, pp. 185-187
MECHANISMS OF ENHANCED ORAL AVAILABILITY OF CYP3A4 SUBSTRATES BY GRAPEFRUIT CONSTITUENTS - DECREASED ENTEROCYTE CYP3A4 CONCENTRATION AND MECHANISM-BASED INACTIVATION BY FURANOCOUMARINS
Authors: SCHMIEDLINREN P EDWARDS DJ FITZSIMMONS ME HE K LOWN KS WOSTER PM RAHMAN A THUMMEL KE FISHER JM HOLLENBERG PF WATKINS PB
Citation: P. Schmiedlinren et al., MECHANISMS OF ENHANCED ORAL AVAILABILITY OF CYP3A4 SUBSTRATES BY GRAPEFRUIT CONSTITUENTS - DECREASED ENTEROCYTE CYP3A4 CONCENTRATION AND MECHANISM-BASED INACTIVATION BY FURANOCOUMARINS, Drug metabolism and disposition, 25(11), 1997, pp. 1228-1233
EXPRESSION OF ENZYMATICALLY ACTIVE CYP3A4 BY CACO-2 CELLS GROWN ON EXTRACELLULAR MATRIX-COATED PERMEABLE SUPPORTS IN THE PRESENCE OF 1-ALPHA,25-DIHYDROXYVITAMIN D-3
Authors: SCHMIEDLINREN P THUMMEL KE FISHER JM PAINE MF LOWN KS WATKINS PB
Citation: P. Schmiedlinren et al., EXPRESSION OF ENZYMATICALLY ACTIVE CYP3A4 BY CACO-2 CELLS GROWN ON EXTRACELLULAR MATRIX-COATED PERMEABLE SUPPORTS IN THE PRESENCE OF 1-ALPHA,25-DIHYDROXYVITAMIN D-3, Molecular pharmacology, 51(5), 1997, pp. 741-754
GRAPEFRUIT JUICE INCREASES FELODIPINE ORAL AVAILABILITY IN HUMANS BY DECREASING INTESTINAL CYP3A PROTEIN EXPRESSION
Authors: LOWN KS BAILEY DG FONTANA RJ JANARDAN SK ADAIR CH FORTLAGE LA BROWN MB GUO WS WATKINS PB
Citation: Ks. Lown et al., GRAPEFRUIT JUICE INCREASES FELODIPINE ORAL AVAILABILITY IN HUMANS BY DECREASING INTESTINAL CYP3A PROTEIN EXPRESSION, The Journal of clinical investigation, 99(10), 1997, pp. 2545-2553
SHORT-TERM EFFECT OF MEDICATIONS ON CYP3A4 AND P-GLYCOPROTEIN EXPRESSION IN HUMAN INTESTINAL-MUCOSA
Authors: WILLE RT LOWN KS HUSZCZO UR SCHMIEDLINREN P WATKINS PB
Citation: Rt. Wille et al., SHORT-TERM EFFECT OF MEDICATIONS ON CYP3A4 AND P-GLYCOPROTEIN EXPRESSION IN HUMAN INTESTINAL-MUCOSA, Gastroenterology, 112(4), 1997, pp. 419-419
EFFECTS OF A CHARGRILLED MEAT DIET ON HUMAN LIVER AND INTESTINAL CYP3A4 AND CYP1A EXPRESSION
Authors: FONTANA RJ LOWN KS FORTLAGE LA JANARDAN SK ADAIR CH WATKINS PB
Citation: Rj. Fontana et al., EFFECTS OF A CHARGRILLED MEAT DIET ON HUMAN LIVER AND INTESTINAL CYP3A4 AND CYP1A EXPRESSION, Gastroenterology, 112(4), 1997, pp. 875-875
GRAPEFRUIT JUICE INCREASES FELODIPINE ORAL AVAILABILITY IN MAN BY DECREASING INTESTINAL CYP3A4 PROTEIN
Authors: LOWN KS FONTANA RJ JANARDAN SK BAILEY DG FORTLAGE LA ADAIR CH WATKINS PB
Citation: Ks. Lown et al., GRAPEFRUIT JUICE INCREASES FELODIPINE ORAL AVAILABILITY IN MAN BY DECREASING INTESTINAL CYP3A4 PROTEIN, Gastroenterology, 112(4), 1997, pp. 890-890
ROLE OF INTESTINAL P-GLYCOPROTEIN (MDR1) IN INTERPATIENT VARIATION INTHE ORAL BIOAVAILABILITY OF CYCLOSPORINE
Authors: LOWN KS MAYO RR LEICHTMAN AB HSIAO HL TURGEON DK SCHMIEDLINREN P BROWN MB GUO WS ROSSI SJ BENET LZ WATKINS PB
Citation: Ks. Lown et al., ROLE OF INTESTINAL P-GLYCOPROTEIN (MDR1) IN INTERPATIENT VARIATION INTHE ORAL BIOAVAILABILITY OF CYCLOSPORINE, Clinical pharmacology and therapeutics, 62(3), 1997, pp. 248-260
SELECTIVE EXPRESSION OF CYP3A5 AND NOT CYP3A4 IN HUMAN BLOOD
Authors: JANARDAN SK LOWN KS SCHMIEDLINREN P THUMMEL KE WATKINS PB
Citation: Sk. Janardan et al., SELECTIVE EXPRESSION OF CYP3A5 AND NOT CYP3A4 IN HUMAN BLOOD, Pharmacogenetics, 6(5), 1996, pp. 379-385
INDUCTION OF MDR1 EXPRESSION IN NORMAL RAT AND HUMAN INTESTINE IN-VIVO
Authors: LOWN KS KOLARS JC GHOSH M SCHMIEDLINREN P WATKINS PB
Citation: Ks. Lown et al., INDUCTION OF MDR1 EXPRESSION IN NORMAL RAT AND HUMAN INTESTINE IN-VIVO, Gastroenterology, 110(4), 1996, pp. 344-344
CYP3A5 AND NOT CYP3A4 IS PRESENT IN PERIPHERAL-BLOOD
Authors: JANARDAN SK LOWN KS SCHMIEDLINREN P WATKINS PB
Citation: Sk. Janardan et al., CYP3A5 AND NOT CYP3A4 IS PRESENT IN PERIPHERAL-BLOOD, Gastroenterology, 110(4), 1996, pp. 1222-1222
INTERPATIENT HETEROGENEITY IN EXPRESSION OF CYP3A4 AND CYP3A5 IN SMALL-BOWEL - LACK OF PREDICTION BY THE ERYTHROMYCIN BREATH TEST (VOL 22, PG 947, 1994)
Authors: LOWN KS KOLARS JC THUMMEL KE BARNETT JL KUNZE KL WRIGHTON SA WATKINS PB
Citation: Ks. Lown et al., INTERPATIENT HETEROGENEITY IN EXPRESSION OF CYP3A4 AND CYP3A5 IN SMALL-BOWEL - LACK OF PREDICTION BY THE ERYTHROMYCIN BREATH TEST (VOL 22, PG 947, 1994), Drug metabolism and disposition, 23(3), 1995, pp. 294-294
INTERINDIVIDUAL VARIATION IN INTESTINAL MDR1 EXPRESSION - LACK OF SHORT-TERM DIET EFFECTS
Authors: LOWN KS FONTANA RJ SCHMIEDLINREN P TURGEON DK WATKINS PB
Citation: Ks. Lown et al., INTERINDIVIDUAL VARIATION IN INTESTINAL MDR1 EXPRESSION - LACK OF SHORT-TERM DIET EFFECTS, Gastroenterology, 108(4), 1995, pp. 737-737
THE ERYTHROMYCIN BREATH TEST PREDICTS THE CLEARANCE OF MIDAZOLAM
Authors: LOWN KS THUMMEL KE BENEDICT PE SHEN DD TURGEON DK BERENT S WATKINS PB
Citation: Ks. Lown et al., THE ERYTHROMYCIN BREATH TEST PREDICTS THE CLEARANCE OF MIDAZOLAM, Clinical pharmacology and therapeutics, 57(1), 1995, pp. 16-24
CYP3A GENE-EXPRESSION IN HUMAN GUT EPITHELIUM
Authors: KOLARS JC LOWN KS SCHMIEDLINREN P GHOSH M FANG C WRIGHTON SA MERION RM WATKINS PB
Citation: Jc. Kolars et al., CYP3A GENE-EXPRESSION IN HUMAN GUT EPITHELIUM, Pharmacogenetics, 4(5), 1994, pp. 247-259
INTERPATIENT HETEROGENEITY IN EXPRESSION OF CYP3A4 AND CYP3A5 IN SMALL-BOWEL - LACK OF PREDICTION BY THE ERYTHROMYCIN BREATH TEST
Authors: LOWN KS KOLARS JC THUMMEL KE BARNETT JL KUNZE KL WRIGHTON SA WATKINS PB
Citation: Ks. Lown et al., INTERPATIENT HETEROGENEITY IN EXPRESSION OF CYP3A4 AND CYP3A5 IN SMALL-BOWEL - LACK OF PREDICTION BY THE ERYTHROMYCIN BREATH TEST, Drug metabolism and disposition, 22(6), 1994, pp. 947-955
PREDICTION OF INTERPATIENT AND INTRAPATIENT VARIATION IN OG-37-325 DOSING REQUIREMENTS BY THE ERYTHROMYCIN BREATH TEST - A PROSPECTIVE-STUDY IN RENAL-TRANSPLANT RECIPIENTS
Authors: TURGEON DK LEICHTMAN AB BLAKE DS SCHMOUDER RL LOWN KS ANNESLEY TM WATKINS PB
Citation: Dk. Turgeon et al., PREDICTION OF INTERPATIENT AND INTRAPATIENT VARIATION IN OG-37-325 DOSING REQUIREMENTS BY THE ERYTHROMYCIN BREATH TEST - A PROSPECTIVE-STUDY IN RENAL-TRANSPLANT RECIPIENTS, Transplantation, 57(12), 1994, pp. 1736-1741
CYP3A5 EXPRESSION IN HUMAN ENTEROCYTES
Authors: JANARDAN SK LOWN KS GHOSH M KOLARS JC WATKINS PB
Citation: Sk. Janardan et al., CYP3A5 EXPRESSION IN HUMAN ENTEROCYTES, Gastroenterology, 106(4), 1994, pp. 10000241-10000241
P450 3A ACTIVITY AND CYCLOSPORINE DOSING IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS
Authors: TURGEON DK LEICHTMAN AB LOWN KS NORMOLLE DP DEEB GM MERION RM WATKINS PB
Citation: Dk. Turgeon et al., P450 3A ACTIVITY AND CYCLOSPORINE DOSING IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS, Clinical pharmacology and therapeutics, 56(3), 1994, pp. 253-260
Risultati: 1-21 |